Bank of America
IDNA icon

Bank of America’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Bank of America’s Portfolio IDNA Stock Details IDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.3M Buy
458,697
+111,992
+32% +$3.25M ﹤0.01% 2734
2025
Q4 		$9.08M Buy
346,705
+58,538
+20% +$1.51M ﹤0.01% 2929
2025
Q3 		$6.8M Buy
288,167
+18,046
+7% +$399K ﹤0.01% 3708
2025
Q2 		$5.54M Sell
270,121
-4,870
-2% -$98.1K ﹤0.01% 3792
2025
Q1 		$5.63M Buy
274,991
+64,203
+30% +$1.43M ﹤0.01% 3690
2024
Q4 		$4.77M Sell
210,788
-117,607
-36% -$2.82M ﹤0.01% 3638
2024
Q3 		$8.08M Buy
328,395
+17,962
+6% +$438K ﹤0.01% 3265
2024
Q2 		$7.18M Buy
310,433
+44,514
+17% +$1.04M ﹤0.01% 3277
2024
Q1 		$6.4M Buy
265,919
+85,727
+48% +$2.01M ﹤0.01% 3401
2023
Q4 		$4.15M Buy
180,192
+40,012
+29% +$804K ﹤0.01% 3705
2023
Q3 		$2.85M Sell
140,180
-135,398
-49% -$3.04M ﹤0.01% 3926
2023
Q2 		$6.44M Buy
275,578
+34,865
+14% +$836K ﹤0.01% 3153
2023
Q1 		$5.6M Buy
240,713
+52,838
+28% +$1.32M ﹤0.01% 3433
2022
Q4 		$4.73M Buy
187,875
+62,759
+50% +$1.69M ﹤0.01% 3437
2022
Q3 		$3.3M Sell
125,116
-24,725
-17% -$763K ﹤0.01% 3789
2022
Q2 		$4.33M Sell
149,841
-203,149
-58% -$6.06M ﹤0.01% 3557
2022
Q1 		$12.2M Buy
352,990
+131,409
+59% +$4.64M ﹤0.01% 2671
2021
Q4 		$9.71M Sell
221,581
-95,934
-30% -$4.54M ﹤0.01% 2962
2021
Q3 		$16.1M Buy
317,515
+190,855
+151% +$9.95M ﹤0.01% 2370
2021
Q2 		$6.59M Sell
126,660
-7,524
-6% -$353K ﹤0.01% 3265
2021
Q1 		$6.13M Buy
134,184
+56,152
+72% +$2.74M ﹤0.01% 3200
2020
Q4 		$3.58M Buy
78,032
+50,842
+187% +$2.2M ﹤0.01% 3445
2020
Q3 		$1.06M Buy
27,190
+21,859
+410% +$840K ﹤0.01% 4165
2020
Q2 		$202K Buy
5,331
+4,331
+433% +$146K ﹤0.01% 5238
2020
Q1 		$27K Buy
+1,000
New +$28.4K ﹤0.01% 6076

Other funds holding IDNA

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
PGA
Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CCA
Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $32.7B AUM 19.2% 1-Year Est. Return

Bank of America's IDNA Position: Q1 2026 in Review

Bank of America increased its iShares Genomics Immunology and Healthcare ETF (IDNA) stake by 32% in Q1 2026, buying an estimated $3.25M and bringing the position to 458,697 shares worth $13.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2734.

Bank of America first reported a position in IDNA in Q1 2020 and has held it in 25 quarters since. The position peaked at $16.1M in Q3 2021. 60 funds tracked by Wall St. Rank hold IDNA as of Q1 2026.

  • Bank of America held 458,697 shares of iShares Genomics Immunology and Healthcare ETF worth $13.3M as of Q1 2026.
  • Bank of America bought 111,992 iShares Genomics Immunology and Healthcare ETF shares in Q1 2026, an estimated $3.25M.
  • iShares Genomics Immunology and Healthcare ETF made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #2734 holding.
  • Bank of America first reported a position in iShares Genomics Immunology and Healthcare ETF in Q1 2020 and has held it in 25 quarters since.
  • Bank of America's iShares Genomics Immunology and Healthcare ETF position peaked at $16.1M in Q3 2021.
  • 60 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.